WebNews

Please enter a web search for web results.

NewsWeb

Google News
crisprmedicinenews. com > news > carbon-newsletter-19-june-2026-your-latest-news-about-crispr-in-agrobio

News: CARBON Newsletter (19 June 2026) - Your Latest News About CRISPR in Agro Bio - CRISPR Medicine

1+ day, 4+ hour ago  (1021+ words) News: CARBON Newsletter (19 June 2026) - Your Latest News About CRISPR in Agro Bio CRISPR Medicine News CARBON Newsletter (19 June 2026) - Your Latest News About CRISPR in Agro Bio Some of the best links we picked up around the internet CRISPR Agro Bio…...

Symbols: nasdaq:crsp
CRISPR Medicine
crisprmedicinenews. com > press-release-service > card > more-than-100-scientific-papers-leveraged-the-dante-labs-technology-for-research-on-transcriptomics

Press Release Service: More Than 100 Scientific Papers Leveraged the Dante Labs Technology for Research on Transcriptomics, CRISPR Gene Editing, Ancient DNA samples, Rare Diseases and Oncology

1+ day, 13+ hour ago  (185+ words) Peer reviewed studies include: NEW YORK--(BUSINESS WIRE)--Dante Labs enabled more than 100 global scientific studies on rare diseases, transcriptomics, CRISPR gene editing ancient DNA samples and oncology. Dante Labs also published its own papers on peer reviewed journals, including…...

Symbols: nasdaq:txg,btc-usd
CRISPR Medicine
crisprmedicinenews. com > press-release-service > card > scribe-therapeutics-awarded-more-than-25-million-from-cirm-to-accelerate-additional-crispr-based-ge

Press Release Service: Scribe Therapeutics Awarded More Than $25 Million From CIRM to Accelerate Additional CRISPR-Based Gene Editing Therapies for Cardiometabolic Disease Into Clinical Trials

1+ day, 13+ hour ago  (997+ words) CRISPR Medicine News Scribe Therapeutics Awarded More Than $25 Million From CIRM to Accelerate Additional CRISPR-Based Gene Editing Therapies for Cardiometabolic Disease Into Clinical Trials - Scribe received multi-year grant awards from the California Institute for Regenerative Medicine (CIRM) to advance two…...

Symbols: nasdaq:crsp
CRISPR Medicine
crisprmedicinenews. com > news > clinical-caribous-off-the-shelf-car-t-drives-durable-myeloma-responses

News: Clinical: Caribous' Off-The-Shelf Car-T Drives Durable Myeloma Responses

4+ day, 35+ min ago  (339+ words) Clinical: Caribous' Off-The-Shelf Car-T Drives Durable Myeloma Responses CRISPR Medicine News Clinical: Caribous' Off-The-Shelf Car-T Drives Durable Myeloma Responses Updated phase 1 data indicate that a single infusion of Caribou Biosciences' CB-011, an allogeneic anti-BCMA CAR-T cell therapy, can induce deep…...

Symbols: iec-ec
CRISPR Medicine
crisprmedicinenews. com > press-release-service > card > ai-lab-radical-numerics-launches-with-50m-seed-round-to-build-general-biological-intelligence

Press Release Service: AI Lab Radical Numerics Launches with $50 M Seed Round To Build General Biological Intelligence

4+ day, 13+ hour ago  (638+ words) AI Lab Radical Numerics Launches with $50 M Seed Round To Build General Biological Intelligence CRISPR Medicine News AI Lab Radical Numerics Launches with $50 M Seed Round To Build General Biological Intelligence Founded by the team who created the field of…...

Symbols: btc-usd
CRISPR Medicine
crisprmedicinenews. com > news > caribous-off-the-shelf-car-t-drives-durable-myeloma-responses

News: Caribous' Off-The-Shelf Car-T Drives Durable Myeloma Responses

5+ day, 1+ hour ago  (328+ words) Caribous' Off-The-Shelf Car-T Drives Durable Myeloma Responses CRISPR Medicine News Caribous' Off-The-Shelf Car-T Drives Durable Myeloma Responses Updated phase 1 data indicate that a single infusion of Caribou Biosciences' CB-011, an allogeneic anti-BCMA CAR-T cell therapy, can induce deep and durable…...

Symbols: iec-ec
CRISPR Medicine
crisprmedicinenews. com > press-release-service > card > vertex-presents-new-data-on-casgevyr-including-first-european-presentation-of-data-in-children-ages

Press Release Service: Vertex Presents New Data on CASGEVY, Including First European Presentation of Data in Children Ages 511, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions

1+ week, 2+ day ago  (683+ words) - Data from pivotal studies of CASGEVY in children ages 511 with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrate transformative potential in younger patients, consistent with the durable benefits established in patients 12 years and older - - Data simultaneously published in the…...

Symbols: btc-usd,nasdaq:incy
CRISPR Medicine
crisprmedicinenews. com > press-release-service > card > watchmaker-to-unveil-new-technologies-addressing-ngs-workflow-bottlenecks-and-sequencing-accuracy-ch

Press Release Service: Watchmaker to Unveil New Technologies Addressing NGS Workflow Bottlenecks and Sequencing Accuracy Challenges at ESHG 2026

1+ week, 3+ day ago  (332+ words) Sequencing workflows continue to grow in scale and complexity, but many of the core bottlenecks researchers face today remain fundamentally unchanged," said Trey Foskett, CEO of Watchmaker. These launches reflect our focus on engineering technologies that not only improve data…...

Symbols: btc-usd
CRISPR Medicine
crisprmedicinenews. com > news > base-editing-rewrites-embryo-genomes-precisely

News: Base Editing Rewrites Embryo Genomes Precisely

1+ week, 4+ day ago  (395+ words) Base Editing Rewrites Embryo Genomes Precisely CRISPR Medicine News Base Editing Rewrites Embryo Genomes Precisely Researchers have reported the first use of CRISPR-derived base editing to make precise DNA changes in human embryos while avoiding the large chromosomal abnormalities commonly…...

Symbols: ticker:clls,ticker:alcls
CRISPR Medicine
crisprmedicinenews. com > press-release-service > card > seek-labs-maps-2525-viral-families-through-bioseeker-advancing-a-new-model-for-sequence-directed-a

Press Release Service: Seek Labs Maps 25/25 Viral Families through Bio Seeker, Advancing a New Model for Sequence-Directed Antiviral Discovery

1+ week, 4+ day ago  (202+ words) Seek Labs" approach is built for this gap. By mapping CRISPR-addressable regions across the viral families known to infect humans, the company addresses one of the earliest bottlenecks in outbreak response: identifying biologically relevant viral target regions quickly enough to…...

Symbols: asx:ila